Announced Wed, 13 May · 16:08 IST

In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of electronic Extraordinary ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹9.70
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-5.8+12.9+12.4+14.0+30.2+11.8+10.8-1.6
Up moveDown movePending
AI summary

Gennex Laboratories Limited held its Extraordinary General Meeting on May 12, 2026 via video conferencing. The only agenda item was the regularization of Ms. Khushbu Kachhawa (DIN: 10872432) as a Non-Executive Independent Woman Director, which was passed as a Special Resolution. Out of 83,897 eligible shareholders, 94 voted (91 remote e-voting + 3 at meeting). Of the 31,176,136 votes cast, 31,176,049 (99.9997%) were in favour and only 87 votes were against. Promoter and Promoter Group voted entirely in favour (100%). The resolution was approved with the required majority and the Scrutinizer's report confirms the outcome.

Likely market impact

The appointment of an independent woman director strengthens the board's independence and diversity, which is a positive governance step. The near-unanimous approval signals strong promoter backing and should be viewed neutrally to positively by the market.